Food & Flavor Manufacturing Regulatory Intelligence North America | June 18–26, 2026
June 24 — FDA phthalates in food-contact materials
FDA updated its phthalates page and extended comments to July 26, 2026 on grouping DEHP, DCHP, DIOP, and DINP for future cumulative risk assessment. This affects packaging, PVC/vinyl tubing, gaskets, adhesives, lubricants, sealants, conveyor belts, and other food-contact systems used by food and flavor manufacturers. FDA says nine phthalates remain authorized in food-contact applications, but it is continuing post-market safety review. Manufacturers should review supplier letters of guarantee, food-contact declarations, and high-fat or oil-based flavor exposure risks. (U.S. Food and Drug Administration)
June 25 — FDA food additive petition: irradiation of raw enriched wheat flour
FDA filed a food additive petition from Sterigenics U.S., LLC seeking to amend 21 CFR 179.26 to allow ionizing radiation to reduce pathogens in raw enriched wheat flour, up to 30 kGy. This is highly relevant to flour mills, bakery manufacturers, dry-mix producers, and flavor/seasoning suppliers using flour carriers. If approved, it could create a new pathogen-control option for a historically high-risk low-moisture ingredient. (Federal Register)
June 22 — EPA pesticide residue petitions for food commodities
EPA published notice of pesticide petitions seeking establishment or modification of residue regulations for chemicals on various commodities, with comments due July 22, 2026. This matters for ingredient sourcing, especially botanical extracts, spices, fruit/vegetable ingredients, and agricultural raw materials used in flavors. Tolerances affect whether treated commodities can lawfully enter U.S. food channels. (Federal Register)
June 18 — FDA dietary supplement CGMP information collection
FDA submitted the 21 CFR Part 111 dietary supplement CGMP information collection to OMB, with comments due July 20, 2026. This affects supplement manufacturers and ingredient/flavor suppliers serving gummies, powders, capsules, functional beverages, and nutraceutical products. FDA emphasized records for sanitation, equipment, water, process controls, quality control, components, packaging, labels, master manufacturing, lab operations, returns, and complaints. (Federal Register)
June 18 — FDA medicated feed CGMP recordkeeping update
FDA submitted revisions for CGMP recordkeeping covering Type A medicated articles and medicated feeds. While animal-feed focused, it affects food-chain safety through residue control in animal-derived ingredients. FDA noted records are needed to monitor drug use, misformulation, recalls, product defects, and violative residues. This is relevant to meat, dairy, egg, and pet-food adjacent ingredient suppliers. (Federal Register)
June 18 — FDA extralabel drug use in animals information collection
FDA opened comment on reporting requirements for extralabel drug use in animals, with comments due August 17, 2026. The manufacturing impact is indirect but important: animal-drug residue policy affects meat, poultry, dairy, egg, gelatin, collagen, and other animal-derived inputs used in food and flavor systems. (Federal Register)
June 18 — FSIS egg products food-safety guideline comments
FSIS’s June 18 constituent update flagged the comment period for the revised Food Safety Guideline for Egg Products, open until July 6, 2026. This matters for egg-product processors and manufacturers using liquid, dried, frozen, or RTE egg ingredients in bakery, sauces, dressings, flavors, and prepared foods. (Food Safety and Inspection Service)
June 18 — FSIS RTE questionnaire/import-refusal data updates
FSIS also reported refinements to its RTE weekly questionnaire and import refusal datasets. This affects RTE meat/poultry processors and suppliers of seasonings, marinades, coatings, and post-lethality ingredients, because customer audits may increasingly request stronger documentation for Listeria control, allergen control, and import eligibility. (Food Safety and Inspection Service)